These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34385616)

  • 1. Treatment of relapsed aggressive adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation with mogamulizumab followed by lenalidomide.
    Tamai H; Tajika K; Nakayama K; Arai A
    Bone Marrow Transplant; 2021 Nov; 56(11):2862-2863. PubMed ID: 34385616
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment with mogamulizumab or lenalidomide for relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: The Nagasaki transplant group experience.
    Sakamoto H; Itonaga H; Sawayama Y; Furumoto T; Fujioka M; Chiwata M; Toriyama E; Kasai S; Nakashima J; Horai M; Kato T; Sato S; Ando K; Taguchi J; Imaizumi Y; Yoshida S; Hata T; Moriuchi Y; Miyazaki Y
    Hematol Oncol; 2020 Apr; 38(2):162-170. PubMed ID: 31922287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation.
    Inoue Y; Endo S; Matsuno N; Kikukawa Y; Shichijo T; Koga K; Takaki A; Iwanaga K; Nishimura N; Fuji S; Fukuda T; Nosaka K; Matsuoka M
    Bone Marrow Transplant; 2019 Feb; 54(2):338-342. PubMed ID: 30116017
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful treatment of a patient with adult T cell leukemia/lymphoma using anti-CC chemokine receptor 4 monoclonal antibody mogamulizumab followed by allogeneic hematopoietic stem cell transplantation.
    Motohashi K; Suzuki T; Kishimoto K; Numata A; Nakajima Y; Tachibana T; Ohshima R; Kuwabara H; Tanaka M; Tomita N; Ishigatsubo Y; Fujisawa S
    Int J Hematol; 2013 Aug; 98(2):258-60. PubMed ID: 23801427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete response following toxic epidermal necrolysis in relapsed adult T cell leukemia/lymphoma after haploidentical stem cell transplantation.
    Morishige S; Nishi M; Saruta H; Arakawa F; Yamasaki Y; Oya S; Nakamura T; Seki R; Yamaguchi M; Aoyama K; Mouri F; Osaki K; Ohshima K; Nagafuji K
    Int J Hematol; 2019 Oct; 110(4):506-511. PubMed ID: 31152415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment approach for relapse of adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation].
    Kato K
    Rinsho Ketsueki; 2021; 62(5):505-511. PubMed ID: 34248128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow-up of a randomised phase II study of chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: impact on allogeneic haematopoietic stem cell transplantation.
    Ishida T; Jo T; Takemoto S; Suzushima H; Suehiro Y; Choi I; Yoshimitsu M; Saburi Y; Nosaka K; Utsunomiya A; Kobayashi Y; Yamamoto K; Fujiwara H; Ishitsuka K; Yoshida S; Taira N; Imada K; Kato K; Moriuchi Y; Yoshimura K; Takahashi T; Tobinai K; Ueda R
    Br J Haematol; 2019 Feb; 184(3):479-483. PubMed ID: 29411857
    [No Abstract]   [Full Text] [Related]  

  • 8. Severe graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with residual mogamulizumab concentration.
    Hosoi H; Mushino T; Nishikawa A; Hashimoto H; Murata S; Hatanaka K; Tamura S; Hanaoka N; Shimizu N; Sonoki T
    Int J Hematol; 2018 Jun; 107(6):717-719. PubMed ID: 29671245
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment with mogamulizumab followed by allogeneic hematopoietic stem-cell transplantation in adult T-cell leukemia/lymphoma: a report of two cases.
    Tsubokura Y; Satake A; Hotta M; Yoshimura H; Fujita S; Azuma Y; Nakanishi T; Nakaya A; Ito T; Ishii K; Nomura S
    Int J Hematol; 2016 Dec; 104(6):744-748. PubMed ID: 27573760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of acute graft-versus-host disease in adult T-cell leukemia-lymphoma patients who received mogamulizumab before allogeneic hematopoietic cell transplantation.
    Inoue Y; Nishimura N; Murai M; Matsumoto M; Watanabe M; Yamada A; Izaki M; Nosaka K; Matsuoka M
    Int J Hematol; 2022 Mar; 115(3):435-439. PubMed ID: 34705226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adult T-cell leukemia/lymphoma].
    Yoshimitsu M
    Rinsho Ketsueki; 2023; 64(9):1032-1040. PubMed ID: 37899180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/lymphoma.
    Ureshino H; Kusaba K; Kidoguchi K; Sano H; Nishioka A; Itamura H; Yoshimura M; Yokoo M; Shindo T; Kubota Y; Ando T; Kojima K; Sueoka E; Kimura S
    Ann Hematol; 2019 Feb; 98(2):465-471. PubMed ID: 30264165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adult T-Cell Leukemia-Lymphoma.
    Munakata W; Tobinai K
    Cancer Treat Res; 2019; 176():145-161. PubMed ID: 30596217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adult T cell leukemia-lymphoma with allo-HSCT after treatment for pulmonary involvement with Mogamulizumab].
    Kawashima I; Sueki Y; Yamamoto T; Nozaki Y; Nakajima K; Mitsumori T; Kirito K
    Rinsho Ketsueki; 2015 Feb; 56(2):210-5. PubMed ID: 25765802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Impact of a Humanized CCR4 Antibody (Mogamulizumab) in 14 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated at a Single Institution During a Three-year Period (2012-2014).
    Kawano N; Kuriyama T; Sonoda KH; Yoshida S; Yamashita K; Ochiai H; Shimoda K; Ishikawa F; Ueda A; Kikuchi I
    Intern Med; 2016; 55(11):1439-45. PubMed ID: 27250049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mogamulizumab for the treatment of relapsed or refractory adult T-cell leukemia-lymphoma.
    Winsett FT; Lewis DJ; Duvic M
    Expert Rev Hematol; 2017 Sep; 10(9):757-760. PubMed ID: 28756726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mogamulizumab Treatment Prior to Allogeneic Hematopoietic Stem Cell Transplantation Induces Severe Acute Graft-versus-Host Disease.
    Sugio T; Kato K; Aoki T; Ohta T; Saito N; Yoshida S; Kawano I; Henzan H; Kadowaki M; Takase K; Muta T; Miyawaki K; Yamauchi T; Shima T; Takashima S; Mori Y; Yoshimoto G; Kamezaki K; Takenaka K; Iwasaki H; Ogawa R; Ohno Y; Eto T; Kamimura T; Miyamoto T; Akashi K
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1608-1614. PubMed ID: 27220263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-haploidentical hematopoietic stem cell transplantation with low-dose thymoglobulin GVHD prophylaxis for an adult T cell leukemia/lymphoma patient treated with pretransplant mogamulizumab.
    Hirosawa M; Higashi T; Iwashige A; Yamaguchi T; Tsukada J
    Ann Hematol; 2017 Feb; 96(2):327-328. PubMed ID: 27766392
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcomes of patients with relapsed aggressive adult T-cell leukemia-lymphoma: clinical effectiveness of anti-CCR4 antibody and allogeneic hematopoietic stem cell transplantation.
    Fuji S; Utsunomiya A; Inoue Y; Miyagi T; Owatari S; Sawayama Y; Moriuchi Y; Choi I; Shindo T; Yoshida SI; Yamasaki S; Yamaguchi T; Fukuda T
    Haematologica; 2018 May; 103(5):e211-e214. PubMed ID: 29371324
    [No Abstract]   [Full Text] [Related]  

  • 20. Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities.
    Hleihel R; Akkouche A; Skayneh H; Hermine O; Bazarbachi A; El Hajj H
    Curr Oncol Rep; 2021 Nov; 23(12):141. PubMed ID: 34735653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.